Search Results - "Sibon, D."

Tandem versus single haematopoietic stem cell transplant and BV maintenance in relapsed/refractory Hodgkin lymphoma: A matched cohort analysis from the LYSA by Marouf, A., Molinari, N., Sibon, D., Cottereau, A. S., Kanoun, S., Antoine, C., Debureaux, P. E., Cavalieri, D., Fornecker, L. M., Casasnovas, R. O., Herbaux, C., Amorim, S., Rossi, C., Bouscary, D., Brice, P., Ghesquieres, H., Tamburini, J., Deau, B.

“…Summary Autologous hematopoietic stem cell transplant (ASCT) is the standard curative treatment for patients with high‐risk relapsed/refractory Hodgkin…”
Get full text

Pre-transplant donor CD4− invariant NKT cell expansion capacity predicts the occurrence of acute graft-versus-host disease by Rubio, M-T, Bouillié, M, Bouazza, N, Coman, T, Trebeden-Nègre, H, Gomez, A, Suarez, F, Sibon, D, Brignier, A, Paubelle, E, Nguyen-Khoc, S, Cavazzana, M, Lantz, O, Mohty, M, Urien, S, Hermine, O

“…Clinically useful pre-transplant predictive factors of acute graft-versus-host-disease (aGVHD) after allogeneic hematopoietic stem cell transplantation…”
Get full text

Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation by Martínez, C., Canals, C., Sarina, B., Alessandrino, E.P., Karakasis, D., Pulsoni, A., Sica, S., Trneny, M., Snowden, J.A., Kanfer, E., Milpied, N., Bosi, A., Guidi, S., de Souza, C.A., Willemze, R., Arranz, R., Jebavy, L., Hellmann, A., Sibon, D., Oneto, R., Luan, J.J., Dreger, P., Castagna, L., Sureda, A.

“…High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is the standard of care for patients with relapsed Hodgkin's lymphoma (HL)…”
Get full text

Brigatinib in patients with ALK‐positive anaplastic large cell lymphoma who have failed brentuximab vedotin by Veleanu, L., Tesson, B., Lamant, L., Marçais, A., Bruneau, J., Kaltenbach, S., Brouzes, C., Degoutte, C., Moraly, J., Villarese, P., Lhermitte, L., Latiri, M., Hure, G., Chauchet, A., Delette, C., Grosleron, S., Toussaint, E., Cabrera, Q., Brice, P., Gros, F., Clavert, A., Oberic, L., Le Goff, M., Cereja, S., Meggetto, F., Macintyre, E., Asnafi, V., Sibon, D.

Get full text

Treatment with anti CD19 CAR‐T cells is safe and effective in patients with relapsed refractory large B‐cell lymphoma with active central nervous system involvement by Marieton, E. Robin, Le Bras, F., Malfuson, J., Camus, V., Legendre, H., Degoutte, C., Gounot, R., Belhadj, K., Sibon, D., Dupuis, J., Kamoun, G., Hammoud, M., El Gnaoui, T., Poullot, E., Ferchiou, A. Beldi, Claudel, A., Menouche, D., Mebarki, M., Dejorna, R., Melica, G., Mekontso‐Dessap, A., Blanc‐Durand, P., Marque, S., Zedet, M., Gendre, T., Haioun, C., Lemonnier, F., Roulin, L.

Get full text

Allogeneic transplantation in T‐cell lymphoma: Lessons from the AATT study by Tournilhac, O., Altmann, B., Friedrichs, B., Bouabdallah, K., Cartron, G., Nickelsen, M., Wulf, G., Leclerc, M., Vilatte, A., Turlure, P., Sanhès, L., Houot, R., Roussel, M., Leval, L., Rosenwald, A., Gaulard, P., Dreger, P., Glass, B., Latière, C., Damaj, G., Lenz, G., Reimer, P., Banos, A., Bilger, K., Durot, E., Sibon, D., Wagner, E., Nguyen, S., Trümper, L., Ziepert, M., Schmitz, N.

Get full text

CHROMATIN ACCESSIBILITY PROFILING TO INCREASE DIAGNOSTIC ACCURACY AND REFINE CELL‐OF‐ORIGIN CLASSIFICATION OF MATURE T‐CELL LYMPHOMAS by Julia, E., Mareschal, S., Chebel, A., Camille, G., Missaglia, E., Rattina, V., Lours, C., Testard, Q., Tschantz, M., Sebai, S., Hadj‐Hamou, S., Bissay, N., Verney, A., Chartoire, D., Marçais, A., Sibon, D., Carras, S., Salles, G., Chassagne‐Clément, C., Martin, L., Szablewski, V., Ruminy, P., Drieux, F., Roussel, M., Louis, S., Bardel, C., Sanlaville, D., Payen, L., Asnafi, V., Herling, M., Baseggio, L., Sujobert, P., Cheminant, M., Laurent, C., Traverse‐Glehen, A., Deleval, L., Gaulard, P., Genestier, L., Bachy, E.

Get full text

LONG‐TERM OUTCOMES OF ELDERLY PATIENTS TREATED WITH FRONTLINE R‐CHOP: UPDATE OF THE LNH03‐6B TRIAL by Camus, V., Belot, Aurél., Oberic, L., Sibon, D., Ghesquières, H., Thieblemont, C., Fruchart, C., Casasnovas, O., Michot, Jean‐M., Molina, T. J., Bosly, A., Joubert, Clém., Haioun, C., Delarue, R., Tilly, H.

Get full text

GENDER DISPARITIES IN QUALITY OF LIFE OF FRENCH PATIENTS ONE YEAR AFTER THE DIAGNOSIS OF LYMPHOMA. A LYSA STUDY by Paunescu, A.‐C., Paget, J., Bergman, C. Copie, Malak, S., Le Gouill, S., Ribrag, V., Bouabdallah, K., Sibon, D., Rumpold, G., Preau, M., Mounier, N., Haioun, C., Jardin, F., Besson, C.

Get full text

Enteropathy-associated T-cell lymphoma: improving treatment strategies by Nijeboer, P, Malamut, G, Mulder, C J, Cerf-Bensussan, N, Sibon, D, Bouma, G, Cellier, C, Hermine, O, Visser, O

“…Enteropathy-associated T-cell lymphoma (EATL) is a rare and usually rapidly fatal intestinal T-cell non-Hodgkin lymphoma. It arises from intraepithelial…”
Get more information

ATEZOLIZUMAB + OBINUTUZUMAB + VENETOCLAX IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: PRIMARY ANALYSIS OF A PHASE 2 TRIAL FROM LYSA by Cartron, G., Bachy, E., Guidez, S., Gyan, E., Gressin, R., Morineau, N., Sibon, D., Casasnovas, O., Le Gouill, S., Tilly, H., Ysebaert, L., Schiano de Colella, J. M., Feugier, P., Virelizier, E. Nicolas, Haioun, C., Damaj, G., Tarte, K., Laurent, C., Houot, R., Thieblemont, C., Morschhauser, F., Herbaux, C.

Get full text

AMAHRELIS : ADCETRIS MAINTENANCE AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IN HODGKIN LYMPHOMA : A REAL LIFE STUDY FROM SFGMTC AND LYSA GROUPS by Marouf, A., Cottereau, A. S., Kanoun, S., Deschamps, P., Franchi, P., Meignan, M., Sibon, D., Gastinne, T., Borel, C., Hammoud, M., Sicard, G., Gille, R., Cavalieri, D., Stamatoullas, A., Clement, L., Lazarovici, J., Chauchet, A., Fornecker, L. M., Amorin, S., Rocquet, M., Raus, N., Burroni, B., Rubio, M. T., Casasnovas, O., Cartron, G., Bouscary, D., Brice, P., Ghesquieres, H., Tamburini, J., Deau, B.

Get full text

POOLED RESULTS OF THREE ANNUAL COHORTS FROM AN OBSERVATIONAL PROSPECTIVE STUDY DESCRIBING BRENTUXIMAB VEDOTIN USE IN ROUTINE PRACTICE IN FRANCE FOR HODGKIN LYMPHOMA: INTERIM ANALYSIS by Sibon, D., Quittet, P., Borel, C., Stamatoullas, A., Franchi‐Rezgui, P., Ghesquieres, H., Dulery, R., Benbrahim, O., Hammoud, M., Durot, E., De Guibert, S., Coulibaly, C., Casasnovas, O., Bouabdallah, R., Brice, P.

Get full text

P1133: SUB‐CUTANEOUS RITUXIMAB INDUCTION FOLLOWED BY SHORT RITUXIMAB MAINTENANCE IMPROVES PFS IN PATIENTS WITH LOW‐TUMOR BURDEN FOLLICULAR LYMPHOMA. FINAL RESULTS OF FLIRT PHASE III TRIAL, A LYSA STUDY by Cartron, G., Bachy, E., Tilly, H., Daguindau, N., Pica, G.‐M., Bijou, F., Mounier, C., Clavert, A. M., Damaj, G. L., Slama, B., Casasnovas, O., Houot, R., Bouabdallah, K., Sibon, D., Fitoussi, O., Morineau, N., Herbaux, C., Gastinne, T., Fornecker, L.‐M., Haioun, C., Launay, V., Araujo, C., Benbrahim, O., Sanhes, L., Gressin, R., Gonzalez, H., Morschhauser, F., Xerri, L., Tarte, K., Pranger, D.

Get full text

MONOMORPHIC EPITHELIOTROPIC INTESTINAL T‐CELL LYMPHOMA (MEITL): CLINICO‐PATHOLOGICAL ANALYSIS OF A MULTICENTER EUROPEAN COHORT by Cavalieri, D., Tournilhac, O., Missiglia, E., Bonnet, C., Ledoux‐Pilon, A., Bisig, B., Cairoli, A., Poullot, E., Fataccioli, V., Parrens, M., Copin, M. C., Gutierrez, F. Llamas, Xerri, L., Bossard, C., De Wind, R., Drieux, F., Lhomme, F., Daniel, A., Clément‐Filliatre, L., Lemmonier, F., Morel, P., Noël, R., Brotelle, T., Glaisner, S., Sibon, D., El Yamani, A., Bologna, S., Queru, K., Damaj, G., Letailleur, V., Villemagne, B., Fleck, E., Dupont, E., Tchernonog, E., Monjanel, H., de Wilde, V., Vallois, D., Gaulard, P., de Leval, L.

Get full text

FIRST‐LINE THERAPY OF T‐CELL LYMPHOMA: ALLOGENEIC OR AUTOLOGOUS TRANSPLANTATION FOR CONSOLIDATION ‐ FINAL RESULTS OF THE AATT STUDY by Tournilhac, O., Truemper, L., Ziepert, M., Bouabdallah, K., Nickelsen, M., Maury, S., Reimer, P., Jaccard, A., Herr, W., Wilhelm, M., Cartron, G., Wulf, G., Sanhes, L., Dreger, P., Lamy, T., Kroschinsky, F., Lindemann, H., Roussel, M., Viardot, A., Sibon, D., Delmer, A., De Leval, L., Damaj, G.L., Gisselbrecht, C., Gaulard, P., Rosenwald, A., Friedrichs, B., Altmann, B., Schmitz, N.

Get full text

Autologous hematopoietic stem cell transplantation in elderly patients (≥ 70 years) with non-Hodgkin's lymphoma: A French Society of Bone Marrow Transplantation and Cellular Therapy retrospective study by Hermet, E, Cabrespine, A, Guièze, R, Garnier, A, Tempescul, A, Lenain, P, Bouabdallah, R, Vilque, J.P, Frayfer, J, Bordessoule, D, Sibon, D, Janvier, M, Caillot, D, Biron, P, Legros, L, Choufi, B, Drenou, B, Gorin, N.C, Bilger, K, Tamburini, J, Soussain, C, Brechignac, S, Bay, J.O

“…Abstract Introduction Limited data is available on the feasibility of high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation…”
Get full text

HTLV-1 propels untransformed CD4 lymphocytes into the cell cycle while protecting CD8 cells from death by Sibon, David, Gabet, Anne-Sophie, Zandecki, Marc, Pinatel, Christiane, Thête, Julien, Delfau-Larue, Marie-Hélène, Rabaaoui, Samira, Gessain, Antoine, Gout, Olivier, Jacobson, Steven, Mortreux, Franck, Wattel, Eric

“…Human T cell leukemia virus type 1 (HTLV-1) infects both CD4+ and CD8+ lymphocytes, yet it induces adult T cell leukemia/lymphoma (ATLL) that is regularly of…”
Get full text

PROGNOSTIC FACTORS AND IMPACT OF ETOPOSIDE IN ADULTS WITH SYSTEMIC ALK‐POSITIVE ANAPLASTIC LARGE‐CELL LYMPHOMA: A POOLED ANALYSIS OF SIX STUDIES by Sibon, D., Nguyen, D., Schmitz, N., Suzuki, R., Feldman, A.L., Gressin, R., Lamant, L., Weisenburger, D., Nakamura, S., Ziepert, M., Maurer, M.J., Bast, M., Armitage, J.O., Vose, J.M., Tilly, H., Jais, J.P., Savage, K.J.

Get full text

NKP46 EXPRESSION IS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER IN PRIMARY GASTROINTESTINAL T‐CELL LYMPHOPROLIFERATIONS. A CELAC NETWORK STUDY by Cheminant, M., Bruneau, J., Malamut, G., Sibon, D., Guegan, N., Trinquand, A., Lhermitte, L., Brousse, N., Suarez, F., Frenzel, L., Delarue, R., Marçais, A., Macintyre, E., Asnafi, V., Lhospice, F., Bonnafous, C., Molina, T., Meresse, B., Cellier, C., Cerf‐Bensussan, N., Hermine, O.

Get full text